MedImpact Healthcare Systems, Inc. will begin processing for Vensurance as of 9/1/2016.  

Since you have already agreed to participate with MedImpact, there will be no information for you to return.  Enclosed please find the following information to assist you in processing claims:    

• Sample ID Card(s)
• Profile Sheet  

If you have any questions, please feel free to contact our Pharmacy Help Desk at 888-807-9798 on or after 9/1/2016.  

Thank you.

*Please see attached PDF for more information.

Dear Provider:

Effective immediately, updates were made to the Provider Portal (Pharmacy Handbook). You are required to review the Portal at your earliest convenience. Check the Latest News, Pharmacy Communications, Health & Drug information, Resource tools, Benefit Programs, Customer Service Information, and other sources found on our website at http://www.envisionrx.com

Locate the Provider Portal at https://www.envisionrx.com/pdf/ProviderPortal.pdf

Should you have any questions, please contact the Envision Pharmacy Help Desk at 1-800-361-4542.

Thank you,

EnvisionRxOptions

Effective Date: 11/01/2016

Cook County Health and Hospitals Systems

Attention Pharmacy Staff: CountyCare, an Illinois Medicaid plan serving Cook County, will be making changes to the formulary effective 11/01/2016. The below communication is being sent to members in September to alert them of the change of the types of glucose monitors and test strips that will be available in their formulary. A code will be provided to the pharmacy staff in the reject message to override and allow a member a one-time fill of their current test strips during the month of November.

*Please see attached PDF for more information.

Effective 10/01/2016, new claims processing functionality will make it quicker and easier for you to resolve Therapeutic Dose Limit (THERDOSE) soft reject edits when dispensing medication for UnitedHealthcare Community Plan in Mississippi members.

THERDOSE screening monitors single ingredient and combination acetaminophen products across multiple claims to determine cumulative daily use. If claims indicate that acetaminophen usage exceeds the U.S. Food and Drug Administration (FDA)-approved maximum daily dose of 4 gm/day, the THERDOSE edit produces a soft reject: Drug Utilization Review (DUR) Reject 88.

*Please see attached PDF for more information.

Effective 10/01/2016, new claims processing functionality will make it quicker and easier for you to resolve Therapeutic Dose Limit (THERDOSE) soft reject edits when dispensing medication for UnitedHealthcare Community Plan in Louisiana members.

THERDOSE screening monitors single ingredient and combination acetaminophen products across multiple claims to determine cumulative daily use. If claims indicate that acetaminophen usage exceeds the U.S. Food and Drug Administration (FDA)-approved maximum daily dose of 4 gm/day, the THERDOSE edit produces a soft reject: Drug Utilization Review (DUR) Reject 88.

*Please see attached PDF for more information.